Extraction and determination of Proscillaridin in Ansal onion native to Iran

Number of pages: 74 File Format: word File Code: 32394
Year: Not Specified University Degree: Not Specified Category: Agricultural Engineering
  • Part of the Content
  • Contents & Resources
  • Summary of Extraction and determination of Proscillaridin in Ansal onion native to Iran

    Persian summary

    Ansul onion, with the scientific name Drimia maritia, is one of the important medicinal plants that has been used in traditional medicine to treat various diseases, including swelling, respiratory disorders, jaundice, and epilepsy.

    Bufadinolides have been identified as the main compounds of this plant. Bufadinolide compound of this plant is Proscillaridin, which has many pharmacological properties. Among the therapeutic effects of prosilaridin, we can mention the following: effectiveness against congestive heart failure, antitumor activity, immunosuppression and analgesic activities. Due to the pharmacological importance of Proscillaridin, in this research, this compound was extracted from Drimia maritia plant in Iran and quantified by valid HPLC method. In order to fully extract Proscillaridin and separate it from other plant compounds, methanol was used as the best extraction solvent and sonification method was used as the best extraction method. Analytical was injected. Proscillaridin was isolated by using a methanol-water gradient system and using a column (6 mm 5µm/4x250ACE C18) and a solvent flow rate equal to 1 ml/min.  The analytical method used to determine the amount of Proscillaridin, which is the most important compound of the plant, was validated. Validation of the method was done using the parameters of selectivity, linearity (r=0.9982), accuracy between days (4.8%), accuracy in one day (0.12%) and accuracy (93.7%). The limit of detection and the limit of quantification have been determined as 0.6 and 1.8 micrograms/ml, respectively. The used method has acceptable precision and accuracy, so it can be used as a UV-HPLC method to determine the amount of Proscillaridin. rtl;">1-1. Necessity and importance of the subject

    Ansal plant with the scientific name Drimia maritima L. is one of the native plants of Iran whose use in native medicine has been common since the ancient civilizations of Iran and Greece. Among the uses of this plant in traditional medicine, expectorant, anti-epileptic and anti-jaundice effects can be mentioned. The main compounds of this plant are cardiac glycosides, which in addition to the known effects on the heart, the anti-cancer effects of these compounds have also been reported in several studies. In this regard, the effects of Ansal onion have been proven in breast cancer and lymphoma, and among the many bufadinolide compounds of this plant, Proscillaridin is known as an effective substance.  Despite the research that has been done so far on this valuable plant, no information has been published in the databases about Ansal onion native to Iran. Due to the increasing spread of traditional medicine and the wide use of this plant in the products available in traditional medicine clinics, it is necessary to determine the amount of the effective substance in order to standardize the products that are prepared from Ansul onion in traditional medicine treatment centers and provided to patients. Therefore, determining the amount of the active ingredient Proscillaridin by high-performance liquid chromatography (HPLC) has been investigated as the subject of this research project.

    1-2. Statement of the problem

    According to the side effects that may occur due to the use of chemical drugs, nowadays the tendency to use herbal drugs that have less side effects has increased. Our country, Iran, has a rich history in the field of traditional medicine. One of the medicinal plants used in traditional Iranian medicine is Ansal onion with the scientific name Drimia maritima L. (1). This plant grows in Fars and Khuzestan provinces (2). Among the uses of Ansal in traditional medicine, we can mention diseases such as epilepsy, shortness of breath, cough, jaundice, and also locally for joint pain and gout (3, 4). The effects that have been proven during many studies of Ansal onion include: cardiac effects similar to digitalis, heart stimulant, antibacterial, diuretic, effect on gout and rheumatism, as well as effect on lymphoma and lung cancer (7, 6, 5).The most important compounds in this plant are bufadinolides from the cardiac glycosides category, among which the largest amount is related to Scillaren A, Scilliroside, Proscillaridin A (6, 8). Cardiac glycosides cause positive inotropic effects on the heart by inhibiting the Na+/K+- ATPase pump (9). These compounds have a low therapeutic index, and even in therapeutic doses, they may cause side effects such as increased heart muscle excitability, irregular heart rhythm, vomiting, diarrhea, loss of appetite, and headache. (6, 9) In order to take advantage of the therapeutic properties of Ansal plant and control its side effects, by determining the amount of effective compounds, the most important of which is Proscillaridin, a suitable method can be provided for the standardization of pharmaceutical products prepared from Ansal. Ahedf

    1. Extraction and determination of Proscillaridin amount in Ansal onion native to Iran

    2. Standardization of products prepared from Ansal onion using determination of Proscillaridin amount by HPLC

    3.

  • Contents & References of Extraction and determination of Proscillaridin in Ansal onion native to Iran

    List:

    None.  

    Source:

    1-Drimia maritima available from www.theplantlist.org

    2- Kaherman, Ahmed. Collection of colorful flora of Iran. Tehran: Institute of Forests and Pastures of Iran. No. 496

    3- Abu Ali Sina. Law in medicine. Translated by Abdulrahman Sharafkandi. Tehran: Soroush Publications; 1368. Book II. p. 261.

    4- Razi Mohammad Bin Zakaria.  Contributor Suleiman Afsharipour. Tehran: Publications of the Academy of Medical Sciences of the Islamic Republic of Iran; 1384. Vol. 20. P. 33

    5- Bozcuk H, [et al]. "Urginea maritima (L.) Baker (Liliaceae) extract induces more cytotoxicity than standard chemotherapeutics in the A549 non-small cell lung cancer (NSCLC) cell line." Turkish Journal of Medical Sciences. 2011. 41(1): 101-108.

    6- David Heber. PDR for herbal medicines. Thomson healthcare Inc. 2007. 785-787.

    7- Hesam R.EI-seed, [et al]. The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: Discovery of an active cardiac glycoside from Urginea maritima. Journal of Ethnopharmacology. 2013;145:746-757

    8- Balbaa SI, Khafagy SM, Khayyal SE, Girgis AN. TLC-Spectrophotometric assay of the main glycosides of Red Squill, A specific rodenticide. Journal of Natural Product. 1979;42:522-524

    9- Charles Evans William. Pharmacognosy of Trez and Evans, Dr. Suleiman Afsharipour. Isfahan University of Medical Sciences; 1386. The second volume. pp. 254-255

    10- Zargari, A. Medicinal plants. Tehran: Publishing and Printing Institute of Tehran University; 1390. The fourth volume. p. 702,703, 658,659

    11- Khare CP. Indian medicinal plants. Berlin: Springer, 2007:590.

    12 - Pohl TS, Crouch NR, Mulholland DR. Southern African Hyacinthaceae: Chemistry, Bioactivity and Ethnobotany. Current Organic Chemistry. 2000;(4):1287-1324

    13- Mozafarian, Waliullah, Knowledge of medicinal and aromatic plants of Iran. Tehran: Farhang Masares Publications; Khuzestan Natural Resources and Livestock Affairs Research Center; 1390.

    The first volume. p. 186

    15 - Cogne AL, Marston A, Mavi S, Hostettmann K. Study of two plants used in traditional medicine in Zimbabwe for skin problems and rheumatism: Dioscoreasylvatica and Urginea altissima. J Ethnopharmacol 2001; 75(1): 51-53.

    16-Pohl T, Koorbanally C, Crouch NR, Mulholland DA. Bufadienolides from Drimia robusta and Urginea altissima (Hyacinthaceae). Phytochemistry 2001; 58 (4): 557-561.

    17-Abdillahi HS, Staden JV. South African plants and male reproductive healthcare: Conception and contraception. J Ethnopharmacol 2012; 143(2), 475-480.

    18-Koorbanally NA, Koorbanally C, Harilal A, Mulholland DA, Crouch NR. Bufadienolides from Drimiarobusta and Urgineaepigea (Hyacinthaceae). Phytochemistry 2004; 65(23): 3069-3073

    19-Aston Philander L, An ethnobotany of Western Cape Rasta bush medicine. J Ethnopharmacol 2011; 138(2): 578-594.

    20-Koorbanally NA, Koorbanally C, Harilal A, Mulholland DA, Crouch NR. Bufadienolides from Drimiarobusta and Urgineaepigea (Hyacinthaceae). Phytochemistry 2004; 65(23): 3069-3073

    21-Du Toit K, Elgorashi EE, Malan SF, Mulholland DA, Drewes SE, Van Staden J. Antibacterial activity and QSAR of homoisoflavanones isolated from six Hyacinthaceae species. S Afr J Bot 2007; 73(2): 236-241.

    22-Crouch NR, Du Toit K, Mulholland DA, Drewes SE. Bufadienolides from bulbs of Urginealydenburgensis (Hyacinthaceae: Urgineoideae). Phytochemistry 2006; 67(19): 2140-2145.

    23-Fennell CW, Light ME, Sparg SG, Stafford GI, VanStaden J. Assessing African medicinal plants for efficacy and safety: agricultural and storage practices. J Ethnopharmacol 2004; 95(2-3): 113-121.

    24-Louw CAM, Regnier TJC, Korsten L. Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious diseases. J Ethnopharmacol 2002; 82(2-3): 147-154.

    25-Ndhlala AR, Finnie JF, VanStaden J. Plant composition, pharmacological properties and mutagenic evaluation of a commercial Zulu herbal. Plant composition, pharmacological properties and mutagenic evaluation of a commercial Zulu herbal mixture: Imbizaephuzwato. J Ethnopharmacol 2011; 133(2): 663-674.

    26-Aston Philander L, An ethnobotany of Western Cape Rasta bush medicine. J Ethnopharmacol 2011; 138(2): 578-594.

    27- Katewa SS, Chaudhary BL, Jain A. Folk herbal medicines from tribal areas of Rajasthan, India. J Ethnopharmacol 2004; 92(1): 41-46.

    28-Kala CP. Aboriginal uses and management of ethnobotanical species in deciduous forests of Chhattisgarh state in India. J Ethnobiol Ethnomed 2009; 5: 1-9.

    29-Jain A, Katewa SS, Galav PK, Sharma P. Medicinal plant diversity of Sitamata wildlife sanctuary, Rajasthan, India. J Ethnopharmacol 2005; 102(2): 143-157.

    30-Choudhary K, Singh M, Phillai U. Ethnobotanical Survey of Rajasthan - An Update. American-Eurasian J Bot 2008; 1: 38-45.

    31-Swarnkar S, Katewa SS. Ethnobotanical observation on tuberous plants from tribal area of ??Rajasthan (India). Ethnobot Leaflets 2008; 12: 647-666.

    32- Abbas S, Bashir S, Khan A, Mehmood MH, Gilani AH. Gastrointestinal stimulant effect of Urgineaindica Kunth. and involvement of muscarinic receptors. Phytother Res 2012; 26(5): 704-708.

    33- Moodley N, Crouch NR, Mulholland DA. Bufadienolides from Drimia macrocentra and Urgineariparia (Hyacinthaceae: Urgineoideae). Phytochemistry 2007; 68(19): 2415-2419.

    34-Marx J, Pretorius E, Espag WJ, Bester MJ. Urgineasanguinea: medicinal wonder or death in disguise? Environ Toxicol Pharmacol 2005; 20(1): 26-34.

    35-Louw CAM, Regnier TJC, Korsten L. Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious diseases. J Ethnopharmacol 2002; 82(2-3): 147-154.

    36-Al-Qura'n S. Ethnopharmacological survey of wild medicinal plants in Showbak, Jordan. J Ethnopharmacol 2009; 123(1): 45-50.

    37-Afifi-Yazar FU, Kasabri V, Abu-dahab R. Medicinal Plants from Jordan in the Treatment of Cancer: Traditional Uses vs. In vitro and in vivo evaluations – Part 1. Planta Med 2011; 77:1203–1209.

    38-Owczarek K. Treating epilepsy: A review of Polish historical sources. Epilepsy Behav 2011; 22(2): 226-230.

    39-Ben?tez G, Gonz?lez-Tejero MR, Molero-Mesa, J. Pharmaceutical ethnobotany in the western part of Granada province (southern Spain): Ethnopharmacological synthesis. J Ethnopharmacol 2010; 129(1): 87-105.

    40- El-Seedi HR, [et al]. The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: Discovery of an active cardiac glycoside from Urgineamaritima. J Ethnopharmacol 2013; 145(3): 746-757.

    41-Sayed MD. Traditional medicine in health care. J Ethnopharmacol 1980; 2(1): 19-22.

    42-Adams M, Berset C, Kessler M, Hamburger M. Medicinal herbs for the treatment of rheumatic disorders—A survey of European herbals from the 16th and 17th centuries. J Ethnopharmacol 2009; 121(3): 343-359.

    43-Leto C, Tuttolomondo T, La Bella S, Licata M. Ethnobotanical study in the Madonie Regional Park (Central Sicily, Italy)—Medicinal use of wild shrub and herbaceous plant species. J Ethnopharmacol 2013; 146(1): 90-112.

    44-Cavallo P, Proto MC, Patruno C, Sorbo AD, Bifulco M. The first cosmetic treatise of history. A female point of view. Int J Cosmet Sci, 2008; 30(2): 79-86.

    45- Marc EB, Nelly A, Annick DD, Frederic D. Plants used as antirheumatic and antineuralgic remedies in the traditional medicine of Lebanon. J Ethnopharmacol 2008;120(3): 315-334.

    46- Saganuwan AS. Tropical plants with antihypertensive, antiasthmatic, and antidiabetic value. J Herbs, Spices Med Plants 2009; 15(1): 24-44.

    47-Sezik E, Ye?ilada E, Honda G, Takaishi Y, Takeda Y, Tanaka T. Traditional medicine in Turkey X. Folk medicine in Central Anatolia. J Ethnopharmacol 2001; 75(2-3): 95-115.

    48-El-Hilaly J, Hmammouchi M, Lyoussi B. Ethnobotanical studies and economic evaluation of medicinal plants in Taounate province (Northern Morocco).

Extraction and determination of Proscillaridin in Ansal onion native to Iran